Showing 81 - 100 of 442 results
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
ANSTO is temporarily housing 12 tonnes of an important chemical for the SABRE Dark Matter Detector as part of the Dark Matter project.
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
The Multi-wavelength absorption black carbon instrument MABI can determine the concentration and source of black carbon pollution.
Exploring the interaction of polystyrene nanoplastics and blood plasma proteins.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.
Polarised neutron scattering on Sika instrument
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
Ultra-realistic simulations of a PET imaging system for next-generation radiotherapy: Collaboration giving back to the open source science community.
Our services include the use of techniques to develop innovative radiation detector technology, such as performing alpha spectroscopy to characterise charge collection capability and radiation transport simulation. We also have expertise in measuring the electrical characteristics of novel detectors and semiconductor devices.
Applications and Publications
Launch of the second phase of construction of the underground laboratory to detect dark matter.
ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.